These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Resistance to activated protein C--frequent etiologic factor for venous thrombosis. Simkova M; Simko F; Kovacs L Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376 [TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden and venous thrombosis in a 4-yr-old girl with Behçet's syndrome. Ihle J; Kümmerle-Deschner J; Orlikowsky T; Albert E; Niethammer D; Dannecker GE Rheumatology (Oxford); 2000 Feb; 39(2):209-10. PubMed ID: 10725075 [No Abstract] [Full Text] [Related]
7. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family. Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408 [No Abstract] [Full Text] [Related]
8. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Rodeghiero F; Tosetto A Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560 [TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A]. Reitsma PH; van de Stolpe A Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene. Castaman G; Ruggeri M; Tosetto A; Rodeghiero F Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717 [No Abstract] [Full Text] [Related]
11. Demystifying two common genetic predispositions to venous thrombosis. Deitcher SR; Caiola E; Jaffer A Cleve Clin J Med; 2000 Nov; 67(11):825-6, 829, 833-6. PubMed ID: 11104333 [TBL] [Abstract][Full Text] [Related]
12. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism? Aras O; Hanson NQ; Tsai MY; Key NS Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451 [No Abstract] [Full Text] [Related]
13. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C. Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosis. Guis-Sabatier S; Roudier J; Arnoux D; Rochwerger A; Roux H; Mattei JP Joint Bone Spine; 2000; 67(2):134-6. PubMed ID: 10769107 [TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease? MacLean RM; Feeney GP; Bowley SJ; Bowen DJ; Worwood M; Collins PW Br J Haematol; 1999 Oct; 107(1):210-2. PubMed ID: 10520044 [TBL] [Abstract][Full Text] [Related]
16. FV and APC resistance: the plot thickens. Castoldi E Blood; 2014 Apr; 123(15):2288-9. PubMed ID: 24723678 [TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden gene mutation in three South African families. Rubinstein R; Bowers D; Novitzky N; Louw I; Jacobs P S Afr Med J; 1999 Feb; 89(2):176. PubMed ID: 10191872 [No Abstract] [Full Text] [Related]
18. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity. Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257 [No Abstract] [Full Text] [Related]
19. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms. Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744 [TBL] [Abstract][Full Text] [Related]